Odisha, India

Abhijit Ray

This inventor holds 2 USPTO granted patents. Top assignee: Rutgers, The State University of New Jersey. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abhijit Ray. Retrieved from https://idiyas.com/inventor/abhijit-ray-nydvosba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Abhijit Ray: Innovator in Cytotoxic Agents

Introduction

Abhijit Ray is a notable inventor based in Orissa, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cytotoxic agents. With a total of 2 patents, his work focuses on therapeutic methods for treating cancer and other conditions.

Latest Patents

Abhijit Ray's latest patents revolve around cytotoxic agents. The inventions provide pharmaceutical compositions comprising compounds that are effective in treating cancer and other topoisomerase-mediated conditions. These patents detail processes for preparing the compounds and intermediates useful for their synthesis.

Career Highlights

Abhijit Ray is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research in pharmaceutical sciences. His work has garnered attention for its potential impact on cancer treatment.

Collaborations

He has collaborated with notable colleagues such as Edmond Joseph LaVoie and Alexander L Ruchelman, contributing to a rich environment of innovation and research.

Conclusion

Abhijit Ray's contributions to the field of cytotoxic agents highlight his commitment to advancing cancer treatment through innovative pharmaceutical solutions. His work continues to inspire future research in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…